Beware of the ambiguous enemy of Multisystem Inflammatory Syndrome in
Adult (MIS-A) following Covid-19 infection or vaccination.
- Ahmad Al Bishawi
, - Maisa Ali,
- Khaled Al-Zubaidi,
- Hamad Abdel Hadi
Ahmad Al Bishawi
Hamad Medical Corporation
Corresponding Author:aalbishawi@hamad.qa
Author ProfileAbstract
Multisystem Inflammatory Syndrome is a rare and novel clinical
presentation described during the evolving Covid- 19 pandemic. The
condition is usually presenting as a sepsis-like syndrome leading to
secondary multiorgan dysfunction post-COVID-19 infection. Although the
syndrome has been mainly described in children, rare adults' form has
been similarly described.22 Sep 2021Submitted to Clinical Case Reports 24 Sep 2021Submission Checks Completed
24 Sep 2021Assigned to Editor
29 Sep 2021Reviewer(s) Assigned
09 Nov 2021Review(s) Completed, Editorial Evaluation Pending
09 Nov 2021Editorial Decision: Revise Minor
14 Nov 20211st Revision Received
16 Nov 2021Submission Checks Completed
16 Nov 2021Assigned to Editor
16 Nov 2021Review(s) Completed, Editorial Evaluation Pending
16 Nov 2021Editorial Decision: Accept
